Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.
Looking for a particular Bioquark Inc. employee's phone or email?
The Bioquark Inc. annual revenue was $9 million in 2026.
Sergei Paylian is the Founder, President and Chief Scientific Officer of Bioquark Inc..
3 people are employed at Bioquark Inc..
Bioquark Inc. is based in Philadelphia, Pennsylvania.
The NAICS codes for Bioquark Inc. are [54171, 5417, 541714, 54, 541].
The SIC codes for Bioquark Inc. are [87, 873].